LABCORP HOLDINGS INC
For the period ended Sep 30, 2024. Filed Oct 29, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Adoption or Termination of Trading Arrangements:
During the fiscal quarter ended September 30, 2024, none of the Company's directors or officers informed it of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:
| Name and Title · Date Adopted · Character of Trading Agreement · Aggregate Number of Shares of Common Stock to be (Sold) Purchased Pursuant to Trading Agreement · Duration | ||||||
|---|---|---|---|---|---|---|
| Adam H. Schechter | August 7, 2024 | Rule 10b5-1 Trading Arrangement | Up to | (27,276) | (1) | 8/29/2025(2) |
| Chief Executive Officer | ||||||
(1)The figure presented represents the shares to be sold on the vesting of equity awards before reduction for shares to be withheld for tax purposes
(2)This trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales on the respective order entry date or (b) the date listed in the table.
INDEX
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.